Clinical Trial Update: Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for FX005 in knee osteoarthritis across Phase 1 and Phase 2, previously completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• FX005

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: COMPLETED